Search research articles
Contact Us
Filters
Showing results (61-70 of 113) with videos related to
Page
of 12
Sort By:
Journal of Medicinal Chemistry
|
September 27, 2022
Identification of Novel 2,4,5-Trisubstituted Pyrimidines as Potent Dual Inhibitors of Plasmodial <i>Pf</i>GSK3/<i>Pf</i>PK6 with Activity against Blood Stage Parasites In Vitro
Kareem A Galal, Anna Truong, Frank Kwarcinski, et al.
Anti-Cancer Drugs
|
December 13, 2024
Screening of a kinase inhibitor library identified novel targetable kinase pathways in triple-negative breast cancer
Caroline H Rinderle, Christopher V Baker, Courtney B Lagarde, et al.
Journal of Medicinal Chemistry
|
November 20, 2020
A Chemical Probe for Dark Kinase STK17B Derives Its Potency and High Selectivity through a Unique P-Loop Conformation
Alfredo Picado, Apirat Chaikuad, Carrow I Wells, et al.
Nature Chemical Biology
|
December 15, 2012
A public-private partnership to unlock the untargeted kinome
Stefan Knapp, Paulo Arruda, Julian Blagg, et al.
Biorxiv : the Preprint Server for Biology
|
May 27, 2024
Discovery and Characterization of a Chemical Probe for Cyclin-Dependent Kinase-Like 2
Frances M Bashore, Sophia M Min, Xiangrong Chen, et al.
ACS Medicinal Chemistry Letters
|
August 14, 2024
Discovery and Characterization of a Chemical Probe for Cyclin-Dependent Kinase-Like 2
Frances M Bashore, Sophia M Min, Xiangrong Chen, et al.
Nature Communications
|
February 14, 2025
Structural insights into human brachyury DNA recognition and discovery of progressible binders for cancer therapy
Joseph A Newman, Angeline E Gavard, Nergis Imprachim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 27, 2021
Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer
Amelia U Schirmer, Lucy M Driver, Megan T Zhao, et al.
Biorxiv : the Preprint Server for Biology
|
November 26, 2025
NUAK2 is a therapeutically tractable regulator of RNA splicing and tumor progression in neuroendocrine prostate cancer
Umar Mehraj, Uran Maimekov, Shaista Manzoor, et al.
Journal of Medicinal Chemistry
|
October 23, 2018
Highly Selective MERTK Inhibitors Achieved by a Single Methyl Group
Jichen Zhao, Dehui Zhang, Weihe Zhang, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 113) with videos related to
Sort By:
Page
of 12
Journal of Medicinal Chemistry
|
September 27, 2022
Identification of Novel 2,4,5-Trisubstituted Pyrimidines as Potent Dual Inhibitors of Plasmodial <i>Pf</i>GSK3/<i>Pf</i>PK6 with Activity against Blood Stage Parasites In Vitro
Kareem A Galal, Anna Truong, Frank Kwarcinski, et al.
Anti-Cancer Drugs
|
December 13, 2024
Screening of a kinase inhibitor library identified novel targetable kinase pathways in triple-negative breast cancer
Caroline H Rinderle, Christopher V Baker, Courtney B Lagarde, et al.
Journal of Medicinal Chemistry
|
November 20, 2020
A Chemical Probe for Dark Kinase STK17B Derives Its Potency and High Selectivity through a Unique P-Loop Conformation
Alfredo Picado, Apirat Chaikuad, Carrow I Wells, et al.
Nature Chemical Biology
|
December 15, 2012
A public-private partnership to unlock the untargeted kinome
Stefan Knapp, Paulo Arruda, Julian Blagg, et al.
Biorxiv : the Preprint Server for Biology
|
May 27, 2024
Discovery and Characterization of a Chemical Probe for Cyclin-Dependent Kinase-Like 2
Frances M Bashore, Sophia M Min, Xiangrong Chen, et al.
ACS Medicinal Chemistry Letters
|
August 14, 2024
Discovery and Characterization of a Chemical Probe for Cyclin-Dependent Kinase-Like 2
Frances M Bashore, Sophia M Min, Xiangrong Chen, et al.
Nature Communications
|
February 14, 2025
Structural insights into human brachyury DNA recognition and discovery of progressible binders for cancer therapy
Joseph A Newman, Angeline E Gavard, Nergis Imprachim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 27, 2021
Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer
Amelia U Schirmer, Lucy M Driver, Megan T Zhao, et al.
Biorxiv : the Preprint Server for Biology
|
November 26, 2025
NUAK2 is a therapeutically tractable regulator of RNA splicing and tumor progression in neuroendocrine prostate cancer
Umar Mehraj, Uran Maimekov, Shaista Manzoor, et al.
Journal of Medicinal Chemistry
|
October 23, 2018
Highly Selective MERTK Inhibitors Achieved by a Single Methyl Group
Jichen Zhao, Dehui Zhang, Weihe Zhang, et al.
Page
of 12